Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>
Mark J. Levis(Sidney Kimmel Cancer Center), Yves Béguin(University of Liège), Jan‐Henrik Mikesch(University Hospital Münster), Melhem Solh(Johns Hopkins Hospital), Nancy L. Geller(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Andrew H. Wei(The Royal Melbourne Hospital), Steven M. Devine(National Marrow Donor Program), Mehdi Hamadani(Medical College of Wisconsin), Edmund K. Waller(Emory University), Sumithra Vasu(The Ohio State University), Nahla Hasabou, Ed Agura, Brent R. Logan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jessica K. Altman(Northwestern University), Denise King, Yi‐Bin Chen(Massachusetts General Hospital), Rishita Nuthethi(Astellas Pharma (United States)), Anurag K. Singh(University Medical Center), Richard J. Jones(Sidney Kimmel Comprehensive Cancer Center), Alexander E. Perl(University of Pennsylvania), Karen K. Ballen(University of Virginia Health System), Walter E. Aulitzky(Robert Bosch Hospital), Masahiro Onozawa(Hokkaido University), Sophia Balderman(Cleveland Clinic), Andrew Artz, Esperanza B. Papadopoulos(Memorial Sloan Kettering Cancer Center), Arnon Nagler(Sheba Medical Center), Guido Marcucci(City of Hope), Jason E. Hill(Essen BioScience (United States)), Adam Mendizabal(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Sarah Anand(University of Michigan), Robert J. Soiffer(Dana-Farber Cancer Institute), Celalettin Üstün(Rush University Medical Center), Yuho Najima(Tokyo Metropolitan Komagome Hospital), Stanley C. Gill(Nivalis Therapeutics (United States)), Asmita Mishra(Moffitt Cancer Center), Mark R. Litzow(Mayo Clinic in Arizona), Michael W. Becker(Helios Hospital Berlin-Buch), Mary M. Horowitz(Medical College of Wisconsin), Hee‐Je Kim(St. Mary's Hospital), Masumi Ueda(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Kirsty Thomson(University College Hospital), David Delgado(Indiana University Hospital), Heather Wittsack(Emmes (United States)), John R. Wingard(University of Florida Health), Matt Rosales(Astellas Pharma (United States)), Lori Muffly(Stanford University)
Cited by 204
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k